THE USE OF INTERFERON SUBTYPE ALPHA 8 IN THE PREPARATION OF MEDICAMENTS TO TREAT VIRAL INFECTIONS OF THE LIVER

PCT No. PCT/GB95/00488 Sec. 371 Date Sep. 24, 1996 Sec. 102(e) Date Sep. 24, 1996 PCT Filed Mar. 7, 1995 PCT Pub. No. WO95/24212 PCT Pub. Date Sep. 14, 1995Individual subtypes of interferon- alpha (IFN- alpha ) have been found to have different antiviral activity in different cell types and are ther...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	THOMAS, HOWARD, CHRISTOPHER, FOSTER, GRAHAM, RUSSELL
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/GB95/00488 Sec. 371 Date Sep. 24, 1996 Sec. 102(e) Date Sep. 24, 1996 PCT Filed Mar. 7, 1995 PCT Pub. No. WO95/24212 PCT Pub. Date Sep. 14, 1995Individual subtypes of interferon- alpha (IFN- alpha ) have been found to have different antiviral activity in different cell types and are therefore used to prevent or treat viral infections in cell types in which they are most active. The individual subtype of choice has relatively low antiviral activity in other celltypes to reduce the risk of side effects. IFN- alpha 10 and/or IFN- alpha 17 are preferred for use in treating viral lung infections and IFN- alpha 8 is preferred for use in treating viral liver infections.